# [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

> **NCT07104487** · PHASE2 · RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 24 (estimated)

## Conditions studied

- Stroke (CVA) or TIA
- Carotid Artery Plaque
- Atherosclerosis Cardiovascular Disease
- Carotid Arteriosclerosis

## Interventions

- **DRUG:** [18F]AlF-OC

## Key facts

- **NCT ID:** NCT07104487
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-18
- **Primary completion:** 2026-09
- **Final completion:** 2029-09
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07104487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07104487, "[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07104487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*